Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy

Published:2018-01-22 Issue:1 Volume:6 Page:
ISSN:2050-7771
Container-title:Biomarker Research
language:en
Short-container-title:Biomark Res

Author:

Wang Zhenguang,Han Weidong

Funder

Science and Technology Planning Project of Beijing City

National Key Research and Development Program of China

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry, medical,Clinical Biochemistry,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40364-018-0116-0.pdf

Reference97 articles.

1. First-Ever CAR. T-cell therapy approved in U.S. Cancer Discov; 2017. https://doi.org/10.1158/2159-8290.CD-NB2017-126 .

2. FDA Approves Second CAR T-cell Therapy. Cancer Discov; 2017. https://doi.org/10.1158/2159-8290.cd-nb2017-155 .

3. DeFrancesco L. CAR-T's forge ahead, despite Juno deaths. Nat Biotechnol. 2017;35:6–7.

4. Teachey DT, Lacey SF, Shaw PA, Melenhorst JJ, Maude SL, Frey N, et al. Identification of predictive biomarkers for cytokine release syndrome after Chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Cancer Discov. 2016;6:664–79.

5. Wang Z, Guo Y, Han W. Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment. Protein Cell; 2017. https://doi.org/10.1007/s13238-017-0400-z .

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence;International Immunopharmacology;2024-10

2. An integrated perspective on measuring cytokines to inform CAR-T bioprocessing;Biotechnology Advances;2024-10

3. Identification of early predictive biomarkers for severe cytokine release syndrome in pediatric patients with chimeric antigen receptor T-cell therapy;Frontiers in Immunology;2024-09-12

4. Targeting TAG-72 in cutaneous T cell lymphoma;Heliyon;2024-09

5. Bayesian network analysis of risk classification strategies in the regulation of cellular products;Artificial Intelligence in Medicine;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3